These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15944054)

  • 1. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges.
    Verstraete AG
    Forensic Sci Int; 2005 Jun; 150(2-3):143-50. PubMed ID: 15944054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current developments in drug testing in oral fluid.
    Pil K; Verstraete A
    Ther Drug Monit; 2008 Apr; 30(2):196-202. PubMed ID: 18367980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legal issues in oral fluid testing.
    Kadehjian L
    Forensic Sci Int; 2005 Jun; 150(2-3):151-60. PubMed ID: 15944055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roadside oral fluid testing: comparison of the results of drugwipe 5 and drugwipe benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood.
    Pehrsson A; Gunnar T; Engblom C; Seppä H; Jama A; Lillsunde P
    Forensic Sci Int; 2008 Mar; 175(2-3):140-8. PubMed ID: 17640837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction and review of collection techniques and applications of drug testing of oral fluid.
    Drummer OH
    Ther Drug Monit; 2008 Apr; 30(2):203-6. PubMed ID: 18367981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
    Davey J; Leal N; Freeman J
    Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical techniques for drug detection in oral fluid.
    Lillsunde P
    Ther Drug Monit; 2008 Apr; 30(2):181-7. PubMed ID: 18367978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid.
    Blencowe T; Pehrsson A; Lillsunde P; Vimpari K; Houwing S; Smink B; Mathijssen R; Van der Linden T; Legrand SA; Pil K; Verstraete A
    Forensic Sci Int; 2011 May; 208(1-3):173-9. PubMed ID: 21183299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers.
    Wille SM; Samyn N; Ramírez-Fernández Mdel M; De Boeck G
    Forensic Sci Int; 2010 May; 198(1-3):2-6. PubMed ID: 19913376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional and alternative matrices for driving under the influence of cannabis: recent progress and remaining challenges.
    Wille SM; Ramírez-Fernandez Mdel M; Samyn N; De Boeck G
    Bioanalysis; 2010 Apr; 2(4):791-806. PubMed ID: 21083274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms.
    Toennes SW; Kauert GF; Steinmeyer S; Moeller MR
    Forensic Sci Int; 2005 Sep; 152(2-3):149-55. PubMed ID: 15978340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs and driving: the Finnish perspective.
    Lillsunde P; Gunnar T
    Bull Narc; 2005; 57(1-2):213-29. PubMed ID: 21338023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bio-analysis of forensically relevant drugs in alternative matrices by liquid chromatography-tandem mass spectrometry.
    Laloup M; Samyn N; Maes V
    Verh K Acad Geneeskd Belg; 2008; 70(5-6):347-67. PubMed ID: 19725394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral fluid testing for cannabis: on-site OraLine IV s.a.t. device versus GC/MS.
    Cirimele V; Villain M; Mura P; Bernard M; Kintz P
    Forensic Sci Int; 2006 Sep; 161(2-3):180-4. PubMed ID: 16854544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs in oral fluid Part II. Investigation of drugs in drivers.
    Wylie FM; Torrance H; Seymour A; Buttress S; Oliver JS
    Forensic Sci Int; 2005 Jun; 150(2-3):199-204. PubMed ID: 15944060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for drugs of abuse: which matrix, oral fluid or urine?
    Allen KR
    Ann Clin Biochem; 2011 Nov; 48(Pt 6):531-41. PubMed ID: 21885472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roadside detection of impairment under the influence of ketamine--evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine.
    Cheng WC; Ng KM; Chan KK; Mok VK; Cheung BK
    Forensic Sci Int; 2007 Jul; 170(1):51-8. PubMed ID: 17046188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for drugs in oral fluid: drug driving and illicit drug use in a sample of Queensland motorists.
    Davey J; Freeman J
    Traffic Inj Prev; 2009 Jun; 10(3):231-6. PubMed ID: 19452364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral fluid collection: the neglected variable in oral fluid testing.
    Crouch DJ
    Forensic Sci Int; 2005 Jun; 150(2-3):165-73. PubMed ID: 15899565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.